Capmatinib for Non Small Cell Lung Cancer User Reviews
Brand names: Tabrecta
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about capmatinib
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
"Tolerated treatment well, and lung tumors decreased significantly in size after 3 months and did not progress after 6 months. The main side effect was swelling (edema) in feet and ankles."